Work

Supplementary Table 6 from Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Overlap between RNAseq datasets from MDA-MB-453 AR-High cells and HCI-009 PDX mice treated with Sevi

DOI: 10.1158/1535-7163.22522291.v1

Authors: Jessica L. Christenson, Kathleen I. O'Neill, Michelle M. Williams, Nicole S. Spoelstra, Kenneth L. Jones, G. Devon Trahan, Jordan Reese, Elaina T. Van Patten, Anthony Elias, Joel R. Eisner, Jennifer K. Richer

Institutions: University of Colorado Anschutz, University of Oklahoma Health Sciences Center, Innocrin Pharmaceuticals (United States)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Funders: U.S. Department of Defense, National Institutes of Health, Cancer Center, University of Colorado, National Cancer Institute

Awards: G1565180698, G301238846, G3984744197, G5443765976, G9000033339, G9000089931, G9000184576, University of Colorado Cancer Center Support Grant, G9001225491

OpenAlex ID: W4362488038

Cites: 55

Cited by:

Related to: 10